Common Contracts
7 similar null contracts by Immunome Inc.
November 30, 2023 Sandra Stoneman Re:Immunome, Inc. Amended and Restated Employment Offer Terms Dear Sandra:Immunome Inc. • March 28th, 2024 • Pharmaceutical preparations
On behalf of Immunome, Inc. (the “Company”), I am pleased to offer you continuing employment as Chief Legal Officer of the Company on the amended terms set forth herein. The purpose of this letter agreement is to set forth the amended terms of your employment should you accept the offer. This letter agreement, if accepted by you, will be effective as of November 1, 2023 (the “Effective Date”). Certain capitalized terms are defined in Section 11 below.
February 7, 2024 Kinney Horn Re:Immunome, Inc. Employment Offer Dear Kinney:Immunome Inc. • March 28th, 2024 • Pharmaceutical preparations
On behalf of Immunome, Inc. (the “Company”), I am pleased to offer you employment as Chief Business Officer of the Company. The purpose of this letter agreement is to set forth the terms of the offer and your employment should you accept the offer. Certain capitalized terms are defined in Section 11 below.
December 14, 2023 Bruce Turner Re:Immunome, Inc. Amended and Restated Employment Offer Terms Dear Bruce:Immunome Inc. • March 28th, 2024 • Pharmaceutical preparations
On behalf of Immunome, Inc. (the “Company”), I am pleased to offer you continuing employment as Chief Strategy Officer of the Company on the amended terms set forth herein. The purpose of this letter agreement is to set forth the amended terms of your employment should you accept the offer. This letter agreement, if accepted by you, will be effective as of November 1, 2023 (the “Effective Date”). Certain capitalized terms are defined in Section 11 below.
November 30, 2023 Jack Higgins Re:Immunome, Inc. Amended and Restated Employment Offer Terms Dear Jack:Immunome Inc. • March 28th, 2024 • Pharmaceutical preparations
On behalf of Immunome, Inc. (the “Company”), I am pleased to offer you continuing employment as Chief Scientific Officer of the Company on the amended terms set forth herein. The purpose of this letter agreement is to set forth the amended terms of your employment should you accept the offer. This letter agreement, if accepted by you, will be effective as of November 1, 2023 (the “Effective Date”). Certain capitalized terms are defined in Section 11 below.
November 30, 2023 Max Rosett Re:Immunome, Inc. Amended and Restated Employment Offer Terms Dear Max:Immunome Inc. • March 28th, 2024 • Pharmaceutical preparations
On behalf of Immunome, Inc. (the “Company”), I am pleased to offer you continuing employment as Senior Vice President (“SVP”), Operations of the Company on the amended terms set forth herein. The purpose of this letter agreement is to set forth the amended terms of your employment should you accept the offer. This letter agreement, if accepted by you, will be effective as of November 1, 2023 (the “Effective Date”). Certain capitalized terms are defined in Section 11 below.
November 30, 2023 Philip Roberts Re:Immunome, Inc. Employment Offer Dear Phil:Immunome Inc. • March 28th, 2024 • Pharmaceutical preparations
On behalf of Immunome, Inc. (the “Company”), I am pleased to offer you employment as Chief Technical Officer of the Company. The purpose of this letter agreement is to set forth the terms of the offer and your employment should you accept the offer. Certain capitalized terms are defined in Section 11 below.
Re:Immunome, Inc. Amended and Restated Employment Offer Terms Dear Bob:Immunome Inc. • March 28th, 2024 • Pharmaceutical preparations
On behalf of Immunome, Inc. (the “Company”), I am pleased to offer you continuing employment as Chief Medical Officer of the Company on the amended terms set forth herein. The purpose of this letter agreement is to set forth the amended terms of your employment should you accept the offer. This letter agreement, if accepted by you, will be effective as of November 1, 2023 (the “Effective Date”).Certain capitalized terms are defined in Section 11 below.
